• Alda 1: ALDH2 Activator Advancing Cardiac Ischemia Research

  2026-07-14

  Alda 1 unlocks new dimensions in cardiac ischemia research by precisely enhancing ALDH2 activity, including the ALDH2*2 variant prevalent in East Asian populations. Its robust, quantifiable effects on cardioprotection and aldehyde detoxification streamline experimental workflows and enable translational innovations in both heart failure and radiation-induced tissue injury.

• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Guidance

  2026-07-13

  FITC-Concanavalin A (ConA) Conjugate enables specific fluorescent detection of α-D-glucose and α-D-mannose residues on cell surfaces, addressing the need for reliable cell surface carbohydrate detection in immunofluorescence and flow cytometry. This reagent is unsuitable for non-carbohydrate targets or workflows outside defined storage and use parameters.

• DAPT (GSI-IX): γ-Secretase Inhibitor for Notch and APP Pathw

  2026-07-13

  DAPT (GSI-IX) is a potent, selective, orally bioavailable γ-secretase inhibitor widely used in Alzheimer's disease and cancer research. Its precise action on Notch signaling and amyloid precursor protein processing aids in dissecting pathway mechanisms and developing targeted experimental workflows.

• α2-Adrenergic Receptor Agonists in Osteosarcoma Recurrence R

  2026-07-12

  This thought-leadership article explores the strategic integration of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, a highly selective α2-adrenergic receptor agonist, into translational research workflows targeting immune rejection modulation and post-surgery osteosarcoma recurrence. We dissect mechanistic insights, highlight rigorous experimental validation, and offer actionable guidance for translational scientists seeking to optimize immune modulation strategies. Drawing on recent advances and competitive intelligence, this piece differentiates itself by connecting the latest mechanistic data to workflow innovation—empowering researchers to move beyond standard product descriptions toward impactful, evidence-led experimentation.

• Chemerin in cNTS Elevates Sympathetic Activity via Superoxid

  2026-07-10

  This study demonstrates that chemerin acting in the caudal nucleus tractus solitarius (cNTS) increases sympathetic nerve activity and blood pressure by activating a CMKLR1–NADPH oxidase–superoxide pathway. The work provides mechanistic clarity on central cardiovascular regulation and precisely distinguishes NMDA from non-NMDA glutamatergic contributions in this brainstem circuit.

• IDH2 Drives CRC Progression via HIF-1α: Metabolic Reprogramm

  2026-07-09

  The referenced study uncovers how elevated IDH2 expression in colorectal cancer cells promotes tumor progression by reprogramming metabolism and stabilizing HIF-1α. Inhibiting IDH2 disrupts this axis by increasing α-ketoglutarate, impairing glycolysis, and suppressing tumor growth, providing a mechanistic framework for targeting metabolic vulnerabilities in CRC.

• SU 5402 in Applied Cancer Biology and Neuronal Assays

  2026-07-09

  SU 5402’s multi-targeted kinase inhibition enables precise dissection of FGFR, VEGFR, and PDGFR pathways in both cancer and neuronal models. This article delivers actionable protocols, troubleshooting strategies, and advanced translational insights for leveraging SU 5402 in cell cycle arrest and apoptosis studies—bridging cancer biology and neurovirology.

• Carvedilol Phosphate: Advancing Ischemia–Reperfusion Injury

  2026-07-08

  Carvedilol Phosphate is redefining experimental precision in hepatic and cardiovascular ischemia–reperfusion injury (IRI) models by enabling robust modulation of GPCR signaling. This article unpacks stepwise protocols, advanced applications, and troubleshooting tips that help researchers maximize reproducibility and mechanistic clarity using this non-selective beta blocker.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Guide and

  2026-07-08

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides a solution for researchers requiring sensitive, specific detection of goat IgG primary antibodies in fluorescence-based assays such as immunocytochemistry, IHC, flow cytometry, and ELISA. It should not be used with non-goat primaries or outside validated immunodetection workflows, as specificity and background may be compromised.

• Technical Use of Angiotensin I/II (1-5) in RAS Research

  2026-07-07

  Angiotensin I/II (1-5) is a defined Asp-Arg-Val-Tyr-Ile peptide fragment for modeling blood pressure regulation and aldosterone signaling within the renin-angiotensin system. It is suitable for cardiovascular and renal workflows but should not be used outside these domains due to its solubility and mechanistic constraints.

• WSP-5: Transforming Live-Cell Imaging of Hydrogen Sulfide Dy

  2026-07-07

  WSP-5 (Washington State Probe-5) delivers unmatched speed and sensitivity for live-cell imaging of hydrogen sulfide, surpassing earlier probes in dynamic disease model studies. Its rapid activation kinetics enable precise monitoring of subtle H2S fluctuations, empowering translational research in cardiovascular, cancer, and metabolic contexts.

• Mecamylamine Hydrochloride: Translational Insights for Gut-B

  2026-07-06

  Discover how Mecamylamine hydrochloride advances gut-brain axis research, with in-depth analysis of cholinergic signaling and neuropsychiatric models. This article uniquely explores its practical and mechanistic roles, referencing groundbreaking findings.

• hiPSC-Derived Intestinal Organoids Transform Pharmacokinetic

  2026-07-06

  Saito et al. introduce a streamlined protocol for generating human intestinal organoids from pluripotent stem cells, enabling more physiologically relevant pharmacokinetic studies. This model addresses key limitations of animal and cancer cell-based systems, with practical implications for drug metabolism and absorption research.

• Simvastatin (Zocor): Advanced Workflows for Cancer and Lipid

  2026-07-05

  Simvastatin (Zocor) uniquely bridges cholesterol-lowering and anti-cancer applications thanks to its potent HMG-CoA reductase inhibition and reliable cellular effects. This guide details optimized protocols, data-driven troubleshooting, and innovative phenotypic profiling strategies for maximizing research outcomes with APExBIO's trusted formulation.

• AO/PI Double Staining Kit: Advanced Cell Viability & Apoptos

  2026-07-04

  The AO/PI Double Staining Kit streamlines high-resolution detection of viable, apoptotic, and necrotic cells, enabling robust single-assay discrimination critical for cancer subtyping and rare cell analysis. With standardized workflows and actionable troubleshooting, this kit empowers translational researchers to achieve reproducible, high-impact results across fluorescence microscopy and flow cytometry platforms.

444 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page